Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CDNF ELISA Kit (AC3341)
Cat.#: ASET-1930
Specifications
Description Human CDNF ELISA Kit allows for the in vitro quantitative determination of human CDNF concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1462 Human Salusin alpha ELISA Kit (AC2873) Quantitative inquiry ASET-2143 Human Ephrin A3 ELISA Kit (AC3554) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1478 Mouse Mitofusin 2 ELISA Kit (AC2889) Quantitative inquiry ASET-1029 Human APLP2 ELISA Kit (AC2440) Quantitative inquiry ASET-1035 Mouse Adiponectin ELISA Kit (AC2446) Quantitative inquiry ASET-1778 Human SLIT3 ELISA Kit (AC3189) Quantitative inquiry ASET-1746 Human TMPRSS4 ELISA Kit (AC3157) Quantitative inquiry ASET-2180 Rat alpha 2a Adrenergic Receptor ELISA Kit (AC3591) Quantitative inquiry ASET-1459 Human KALRN ELISA Kit (AC2870) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket